Roche Pharma has launched Tecentriq, India’s first under-the-skin immunotherapy for non small cell lung cancer. The injection takes about seven minutes, aiming to cut the burden of longer intravenous sessions. By simplifying administration, the company says the treatment can improve patient experience and quality of life while delivering essential cancer care more conveniently.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
